Menu
← Oncology Approval Tracker
FDA DECISION ·
Carfilzomib (Kyprolis first generic)
carfilzomib · Apotex
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Kyprolis 30 mg vial for patients with relapsed or refractory multiple myeloma after one to three prior lines of therapy.
LAMPGEN ANALYSIS
Why it matters
Added an approved generic presentation of the proteasome inhibitor.
What research teams should watch
Verify vial strength and product-specific labeling before updating preparation and inventory rules.
PRIMARY RECORDS